Ann Miller
Director/Board Member chez INOVIO PHARMACEUTICALS, INC.
Fortune : 76 951 $ au 31/03/2024
Postes actifs de Ann Miller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 25/03/2019 | - |
| Independent Dir/Board Member | 25/03/2019 | - | |
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05/10/2020 | - |
| Independent Dir/Board Member | 05/10/2020 | - |
Historique de carrière de Ann Miller
Anciens postes connus de Ann Miller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 01/10/2019 | 31/12/2021 |
| Independent Dir/Board Member | 01/10/2019 | 31/12/2021 | |
| Sanofi SA | Sales & Marketing | 01/01/2012 | 01/09/2018 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
| AMGEN INC. | Sales & Marketing | 01/01/2002 | 01/01/2007 |
Formation de Ann Miller
| Duke University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Japon | 2 |
| France | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Sales & Marketing | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Sanofi SA | Health Technology |
- Bourse
- Insiders
- Ann Miller
- Expérience
